NEW YORK--(BUSINESS WIRE)--The Rosen Law Firm, a global investor rights law firm, announces it is investigating potential securities claims on behalf of investors of Rolta India Limited’s US$200 million 10.75% Senior Notes due 2018 (CUSIP Number: 775793 AA0 (Rule 144A) and U77587 AA8 (Reg. S)) and US$300 million 8.875% Senior Notes due 2019 (CUSIP Number: 775788 AA0 (Rule 144A) and U77583 AA7 (Reg. S)) (together, the “Delaware-issued 2018 and 2019 Corporate Bonds”) resulting from allegations that Rolta India may have issued materially misleading business information to the investing public.
On April 16, 2015, Glaucus Research Group published a report initiating coverage on Rolta India’s Delaware-issued 2018 and 2019 Corporate Bonds with a “strong-sell” recommendation. The report asserts that Rolta India fabricated its reported capital expenditures to conceal that it materially overstated its EBITDA.
The Rosen Law Firm is preparing a class action lawsuit to recover losses suffered by Rolta India investors. If you purchased Rolta India’s Delaware-issued 2018 and 2019 Corporate Bonds, please visit the firm’s website at http://rosenlegal.com/cases-577.html for more information. You may also contact Phillip Kim, Esq. or Kevin Chan, Esq. of The Rosen Law Firm toll free at 866-767-3653 or via email at firstname.lastname@example.org or email@example.com.
The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation.
Attorney Advertising. Prior results do not guarantee a similar outcome.